Sorin Spa Milano (SORJF) 3.1400 $SORJF
Leading 200 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies
M2 - Thu Oct 22, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s5zdn4/global_smallmid) has announced the addition of the "Global Small/Mid Cap Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Small/Mid cap medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information and stock market analysis. The health care sector is expanding as more individuals obtain health insurance yet the investment opportunities are shrinking in market cap. Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector - large-cap stocks. Stunning growth opportunities are found among mid-cap and small cap companies where one to three key products are driving performance. Their size makes them easier to follow and their above-average growth rates make them attractive acquisition targets in a consolidating industry. The median top line growth rate among large-cap companies is at 4%, while that in mid-cap companies is about 7% and that in all the small caps is more than 10%. When we look at a sample of the best in small-cap companies, we are looking at 40% growth. The primary reason large-cap companies don't have small-cap-type growth is that, over the last 20 years, the larger caps have acquired or developed devices in sectors that have been penetrated at significantly higher rates than newer sectors. Revenue growth and gross margin expansion are key factors to consider when valuing a medical device company and, especially, a small- to mid-cap medical device company. Highlights - Leading 200 Global Small/Mid Cap medical devices/technology/supplies companies covered - Provides detailed research methodology for deriving the leading 200 Small/Mid Cap companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Small/Mid Cap medical devices/technology/supplies companies - International presence of Global Small/Mid Cap medical devices/technology/supplies companies - Key R&D activities by Global Small/Mid Cap medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 12 Months: Leading 25 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies with Most Increases 3: Key News of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies for Year 2014-15 4: Key Alliances of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 5: International Presence of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 6: Research and Development Activities by Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - AS One Corporation - Abcam Plc - Advanced Medical Solutions Group PLC - Agfa-Gevaert NV - Ambu A/S - Analogic Corp - Asia Optical Company Incorporated - Capitol Health Ltd - Cellectis SA - Coherent Incorporated - Conmed Corporation - Ebos Group Limited - Ginko International Co Ltd - Gooch & Housego PLC - Greatbatch, Inc. - Hartalega Holdings Bhd - Hogy Medical Company Limited - I - Sens Inc - Icu Medical, Inc. - Ilex Medical Limited - Jeol Limited - Natus Medical, Incorporation - Nolato AB - Novadaq Technologies Inc - Omnicell, Inc. - Sorin SpA - Sun Hing Vision Group Holdings Limited - Sunny Optical Technology (Group) Company Limited - Tamron Co Ltd - Tecan Group AG - Thai Optical Group Public Company Limited - Tornier NV - Value Added Technology Co., Limited. - Vitrolife AB - Wonik Company Limited For more information visit http://www.researchandmarkets.com/research/s5...l_smallmid
ALOG: 87.00 (+1.45), GB: 30.93 (+0.63), TRNX: 20.67 (+0.28), BABY: 38.79 (+0.35), CLLS: 28.35 (+0.66), COHR: 105.87 (-0.20), OMCL: 38.02 (+0.07), NVDQ: 10.79 (+0.08)
Global Medical Devices: Quarterly Investments Review Featuring the Most Recent 200 Business Transactions
M2 - Tue Oct 20, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mqnnl4/global_medical) has announced the addition of the "Global Medical Devices: Quarterly Investments Review " report to their offering. The 'Global Medical Devices: Quarterly Investments Review report' presents the most recent 200 business transactions between the global medical devices/technology/supplies companies are identified, segregated and analyzed to highlight the scope of investments in different sub-industry sectors. Medical device companies are expected to realign their business structures and strategies to compete in the changing global environment (such as growth of emerging markets, health care reform and cost containment). Anticipated changes include company restructuring as well as an increased reliance on strategic alliances and outsourcing for marketing, distribution, research and manufacturing activities. In this context, the author which has been providing company and financial information globally since two decades, brings out Global Medical Devices: Quarterly Investments Review report for global medical devices/technology/supplies companies. Report Highlights: - A guidance business tool which helps the investors in the global medical devices/technology/supplies industry to assess the investment opportunities for the coming months - Helps the investors to familiarize with the existing investment trends in the global medical devices/technology/supplies industry - Helps the global medical devices/technology/supplies companies to know the prevailing sub-industry trends in the global medical devices/technology/supplies business transactions - Presents the key investment strategies applied by the global medical devices/technology/supplies companies - Highlights the favored countries for the deals by the global medical devices/technology/supplies companies - Useful information on trade facilitators' activities to accelerate global medical devices/technology/supplies commerce - Summarizes the recent regulatory developments that are likely to affect the trade approaches of the global medical devices/technology/supplies industry - Summarizes new policies of various governments in global medical devices/technology/supplies industry and its impact on investments globally - Provides at one glance the listing of important transactions across the global medical devices/ technology/supplies sector Companies Mentioned - Simavita Ltd (Australia) - Solborn Incorporated (South Korea) - Sorin SpA (Italy) - Strand Life Sciences Private Limited (India) - Stratec Biomedical AG (Germany) - Straumann Holding AG (Switzerland) - Sunshine Holdings PLC (Sri Lanka) - Sysmex Corporation (Japan) - Thermo Fisher Scientific Inc (United States) - Tornier NV (Netherlands) - Toumaz Limited (United Kingdom) - TSO3 Inc (Canada) - Varian Medical Systems, Inc. (United States) - Vivoline Medical AB (Sweden) - Voxel SA (Poland) - William Demant Holding (Denmark) - Wound Management Technologies, Inc. (United States) - Yamato Scientific Co, Ltd (Japan) - Zecotek Photonics Inc (Canada) - Zhejiang DA Diagnostics Co Ltd (China) For more information visit http://www.researchandmarkets.com/research/mq...al_medical
VAR: 95.25 (+0.43), TRNX: 20.67 (+0.28)
200 Most Diversified Medical Devices/Technology/Supplies Companies Globally
M2 - Tue Oct 20, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lx7zxr/global_most) has announced the addition of the "Global Most Diversified Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Most Diversified medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information, and stock market analysis. The global medical device sector is a highly diversified and export-oriented industry that manufactures medical equipments as well as supplies. The purchasers for the same include hospitals, physician's offices, laboratories, clinics as well as patients (through direct purchases). The sector is populated with companies driven by product innovation. The industry is able to draw on world-class innovative research being conducted in global universities, research institutes, and hospitals, some of which has been spun-off into global medical device companies. Big, highly diversified medical technology companies are tapping into health-care spending spikes in emerging countries. That's in contrast to a U.S. market for medical devices that is mature and slow growing. Emerging market countries have large, aging populations and rising incomes, which equates to 15 percent revenue growth for medical technology companies from those countries. The medical devices/technology sector has become increasingly dominated by larger, diversified companies such as Medtronic, Johnson & Johnson, Boston Scientific Corporation, St. Jude Medical, Guidant Corporation, Stryker Corporation, Zimmer Medical Holdings, Vasomedical, Inc., Integra LifeSciences Holdings Corporation, and many more. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Most Diversified companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Highlights - Leading 200 Global Most Diversified medical devices/technology/supplies companies covered - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Most Diversified medical devices/technology/supplies companies - International presence of Global Most Diversified medical devices/technology/supplies companies - Key R&D activities by Global Most Diversified medical devices/technology/supplies companies Sample list of company names included in this industry report: - 3D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/lx...lobal_most
ATEC: 0.41 (unch), GBSNU: 16.22 (-0.28), MZOR: 23.20 (-0.33), FEIC: 106.68 (+0.12), BSX: 24.14 (unch), JNJ: 124.24 (+0.38), ZLTQ: 35.09 (+0.59), IARTV: 65.00 (-37.45), STJ: 83.90 (+0.45), BVX: 2.86 (+0.26), SYK: 114.90 (+0.05)
Cyberonics Set to Join the S&P MidCap 400; Ruckus Wireless to Join S&P SmallCap 600
PR Newswire - Mon Oct 05, 6:25PM CDT
S&P SmallCap 600 constituent Cyberonics Inc. (NASD:CYBX) will replace Home Properties Inc. (NYSE:HME) in the S&P MidCap 400, and Ruckus Wireless Inc. (NYSE:RKUS) will replace Cyberonics in the S&P SmallCap 600 after the close of trading on Wednesday, October 7. Lone Star Funds is acquiring Home Properties in a deal expected to be completed on or about that date, pending final approvals. Cyberonics is merging with Sorin SpA in a deal expected to be completed soon. Post merger, Cyberonics will change its name to LivaNova plc, and its combined market capitalization is anticipated to be more representative of the mid-cap market space.
HME: 75.24 (+0.01), MHFI: 107.92 (+1.16), RKUS: 12.87 (+0.15), CYBX: 69.95 (+0.86)
Cyberonics' stockholders approve business merger with Sorin to form LivaNova
M2 - Wed Sep 23, 5:05AM CDT
Medical device company Cyberonics (NASDAQ:CYBX) said on Tuesday that its stockholders have voted in favour with a merger and business combination with Sorin SpA (MTA; Reuters Code:SORN.MI)
CYBX: 69.95 (+0.86)
Analyzing the Market for Prosthetic Heart Valves in Russia 2015
M2 - Fri Aug 28, 9:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dpm69l/analyzing_the) has announced the addition of the "Analyzing the Market for Prosthetic Heart Valves in Russia 2015" report to their offering. This research analyzes the market for prosthetic heart valves in Russia in its research report Analyzing the Market for Prosthetic Heart Valves in Russia. The report begins with an overview of prosthetic heart valves. We look at both the mechanical heart valves and the biological heart valves along with the various issues that come up with prosthetic heart valves. The market for prosthetic heart valves is divided into two key types of valve: tissue or biological valves and mechanical heart valves. The tissue valve segment is the largest, with rapid growth expected in between 2014-2019. Mechanical valves remain popular with younger patients. A synthetic or mechanical or natural/biological valve that is surgically placed in place of the existing heart in order to replace the defective or malfunctioning valve is known as a prosthetic heart valve. The mitral and aortic valves are the most commonly replaced with prosthetic heart valves. The market for prosthetic heart valves is growing significantly in Russia especially the market for tissue heart valves. The reason behind this incredible growth is the technological advancements, combined with the launch of transcatheter valves, which is also driving procedure volumes in patients where surgery was not possible earlier due to its challenging nature. Major players in the Russian market for prosthetic heart valves are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic, Inc., amongst others. Key Topics Covered: A. Executive Summary B. Introduction to Prosthetic Heart Valves C. Market for Prosthetic Heart Valves in Russia D. Major Industry Players - Edwards Lifesciences Corporation - Medtronic, Inc - Sorin SpA - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/dp...lyzing_the
MDT: 87.09 (+0.33), STJ: 83.90 (+0.45), EW: 113.23 (+0.25)
Analyzing the Market for Prosthetic Heart Valves in China 2015
M2 - Fri Aug 28, 9:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8b3dbx/analyzing_the) has announced the addition of the "Analyzing the Market for Prosthetic Heart Valves in China 2015" report to their offering. This research analyzes the market for prosthetic heart valves in China in its research report Analyzing the Market for Prosthetic Heart Valves in China. The report begins with an overview of prosthetic heart valves. We look at both the mechanical heart valves and the biological heart valves along with the various issues that come up with prosthetic heart valves. A prosthetic heart valve is a synthetic or mechanical or natural/biological valve surgically placed into the heart to replace a defective or malfunctioning valve. The aortic and mitral valves are the most frequently replaced with prosthetic heart valves. The market for prosthetic heart valves is growing significantly in China, with technological advancements driving the growth, combined with the launch of transcatheter valves, which is also driving procedure volumes in patients where surgery was not possible earlier due to its risky nature. The market for prosthetic heart valves is divided into two key types of valve: tissue and mechanical heart valves. The tissue valve segment is the largest, with rapid growth expected over the reporting period. Mechanical valves remain popular with younger patients. Major players in the Chinese market for prosthetic heart valves are Edwards Lifesciences Corporation, Medtronic, Inc., St. Jude Medical, Inc., amongst others. Key Topics Covered: A. Executive Summary B. Introduction to Prosthetic Heart Valves C. Market for Prosthetic Heart Valves in China D. Major Industry Players - Edwards Lifesciences Corporation - Medtronic, Inc - Sorin SpA - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/8b...lyzing_the
MDT: 87.09 (+0.33), STJ: 83.90 (+0.45), EW: 113.23 (+0.25)
100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gjbtw4/randd_intensive) has announced the addition of the "R&D Intensive Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 R&D Intensive medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Over the past few years the way the medical devices industry assesses innovation and new technology has changed. The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. Recently, global market has been taking the lead in developing lean, frugal, and reverse innovation. This type of innovation simplifies devices and processes, retaining essential functions, while applying new technologies that are more versatile, mobile, and adaptable to consumer's needs and are less expensive. The global companies in medical devices/technology industry are highly R&D intensive and technology based. Such companies, on an average, spend 12% of their revenues on R&D each year in order to develop, design, and commercialize innovative medical devices. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the R&D Intensive companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - R&D Intensive 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of R&D Intensive medical devices/technology/supplies companies with foreign companies - International presence of R&D Intensive medical devices/technology/supplies companies - Key R&D activities by R&D Intensive medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of R&D Intensive Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 R&D Intensive Medical Devices/Technology/Supplies Companies 3: Key News of R&D Intensive Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of R&D Intensive Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by R&D Intensive Medical Devices/Technology/Supplies Companies 6: International Presence of R&D Intensive Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of R&D Intensive Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - 3 D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/gj..._intensive
ATEC: 0.41 (unch), GBSNU: 16.22 (-0.28), MZOR: 23.20 (-0.33), FEIC: 106.68 (+0.12), ZLTQ: 35.09 (+0.59), IART: 84.95 (+0.35), BVX: 2.86 (+0.26)
Leading 100 Medical Devices/Technology/Supplies Companies of Europe 2015
M2 - Mon Mar 23, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wfwcrh/europe_medical) has announced the addition of the "Europe Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical technology is a key driver for Europe's economic well-being, providing quality employment, and a substantial contribution to Europe's balance of trade. The European medical technology market is estimated at roughly 100 billion and is the second largest medical technology market after US. It has been growing on average by 4% per annum over the past 6 years. Through its healthcare innovations, the European medical device industry contributes to ensuring sustainable and accessible healthcare systems throughout Europe. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the European companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Europe - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among European medical devices/technology/supplies companies - International presence of European medical devices/technology/supplies companies - R&D activities by European medical devices/technology/supplies companies Report Includes Companies Engaged in: - Manufacturing medical equipments providing any medical activity and/or treatment - Manufacturing diagnostic equipments - Manufacturing high-tech medical instruments - Manufacturing life-support medical equipments - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products - Manufacturing and/or selling basic medical and surgical materials (consumables), low-tech items and items used in medical equipment processor or for treating patients - Diagnostic equipment supplies - Medical supplies invasive and medical supplies non invasive - Manufacturing/supplying replaceable lenses for equipments - Manufacturing/supplying any item which needs to be replaced as a function of repeated medical activity or where need for treatments is constant - Manufacturing/supplying surgical and dental instruments, elective laser surgery equipments, orthopedic products, and other such products Companies Mentioned - Ion Beam Applications SA (Belgium) - Kitron ASA (Norway) - LiDCO Group PLC (United Kingdom) - MagForce AG (Germany) - Mauna Kea Technologies SAS (France) - Medica AD Sofia (Bulgaria) - Medicrea International (France) - Medisana AG (Germany) - Mercator Medical SA (Poland) - Nobel Biocare Holding AG (Switzerland) - Omega Diagnostics Group Plc (United Kingdom) - Orthofix International N.V. (Netherlands Antilles) - PuriCore PLC (United Kingdom) - PZ Cormay SA (Poland) - Sorin SpA (Italy) - Stentys (France) - Surgical Innovations Group PLC (United Kingdom) - Technoflex SA (France) - Voxel S.A. (Poland) For more information visit http://www.researchandmarkets.com/research/wf...pe_medical
OFIX: 42.42 (+0.13)
Leading 200 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies
M2 - Thu Oct 22, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s5zdn4/global_smallmid) has announced the addition of the "Global Small/Mid Cap Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Small/Mid cap medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information and stock market analysis. The health care sector is expanding as more individuals obtain health insurance yet the investment opportunities are shrinking in market cap. Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector - large-cap stocks. Stunning growth opportunities are found among mid-cap and small cap companies where one to three key products are driving performance. Their size makes them easier to follow and their above-average growth rates make them attractive acquisition targets in a consolidating industry. The median top line growth rate among large-cap companies is at 4%, while that in mid-cap companies is about 7% and that in all the small caps is more than 10%. When we look at a sample of the best in small-cap companies, we are looking at 40% growth. The primary reason large-cap companies don't have small-cap-type growth is that, over the last 20 years, the larger caps have acquired or developed devices in sectors that have been penetrated at significantly higher rates than newer sectors. Revenue growth and gross margin expansion are key factors to consider when valuing a medical device company and, especially, a small- to mid-cap medical device company. Highlights - Leading 200 Global Small/Mid Cap medical devices/technology/supplies companies covered - Provides detailed research methodology for deriving the leading 200 Small/Mid Cap companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Small/Mid Cap medical devices/technology/supplies companies - International presence of Global Small/Mid Cap medical devices/technology/supplies companies - Key R&D activities by Global Small/Mid Cap medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 12 Months: Leading 25 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies with Most Increases 3: Key News of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies for Year 2014-15 4: Key Alliances of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 5: International Presence of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 6: Research and Development Activities by Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - AS One Corporation - Abcam Plc - Advanced Medical Solutions Group PLC - Agfa-Gevaert NV - Ambu A/S - Analogic Corp - Asia Optical Company Incorporated - Capitol Health Ltd - Cellectis SA - Coherent Incorporated - Conmed Corporation - Ebos Group Limited - Ginko International Co Ltd - Gooch & Housego PLC - Greatbatch, Inc. - Hartalega Holdings Bhd - Hogy Medical Company Limited - I - Sens Inc - Icu Medical, Inc. - Ilex Medical Limited - Jeol Limited - Natus Medical, Incorporation - Nolato AB - Novadaq Technologies Inc - Omnicell, Inc. - Sorin SpA - Sun Hing Vision Group Holdings Limited - Sunny Optical Technology (Group) Company Limited - Tamron Co Ltd - Tecan Group AG - Thai Optical Group Public Company Limited - Tornier NV - Value Added Technology Co., Limited. - Vitrolife AB - Wonik Company Limited For more information visit http://www.researchandmarkets.com/research/s5...l_smallmid
ALOG: 87.00 (+1.45), GB: 30.93 (+0.63), TRNX: 20.67 (+0.28), BABY: 38.79 (+0.35), CLLS: 28.35 (+0.66), COHR: 105.87 (-0.20), OMCL: 38.02 (+0.07), NVDQ: 10.79 (+0.08)
Global Medical Devices: Quarterly Investments Review Featuring the Most Recent 200 Business Transactions
M2 - Tue Oct 20, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mqnnl4/global_medical) has announced the addition of the "Global Medical Devices: Quarterly Investments Review " report to their offering. The 'Global Medical Devices: Quarterly Investments Review report' presents the most recent 200 business transactions between the global medical devices/technology/supplies companies are identified, segregated and analyzed to highlight the scope of investments in different sub-industry sectors. Medical device companies are expected to realign their business structures and strategies to compete in the changing global environment (such as growth of emerging markets, health care reform and cost containment). Anticipated changes include company restructuring as well as an increased reliance on strategic alliances and outsourcing for marketing, distribution, research and manufacturing activities. In this context, the author which has been providing company and financial information globally since two decades, brings out Global Medical Devices: Quarterly Investments Review report for global medical devices/technology/supplies companies. Report Highlights: - A guidance business tool which helps the investors in the global medical devices/technology/supplies industry to assess the investment opportunities for the coming months - Helps the investors to familiarize with the existing investment trends in the global medical devices/technology/supplies industry - Helps the global medical devices/technology/supplies companies to know the prevailing sub-industry trends in the global medical devices/technology/supplies business transactions - Presents the key investment strategies applied by the global medical devices/technology/supplies companies - Highlights the favored countries for the deals by the global medical devices/technology/supplies companies - Useful information on trade facilitators' activities to accelerate global medical devices/technology/supplies commerce - Summarizes the recent regulatory developments that are likely to affect the trade approaches of the global medical devices/technology/supplies industry - Summarizes new policies of various governments in global medical devices/technology/supplies industry and its impact on investments globally - Provides at one glance the listing of important transactions across the global medical devices/ technology/supplies sector Companies Mentioned - Simavita Ltd (Australia) - Solborn Incorporated (South Korea) - Sorin SpA (Italy) - Strand Life Sciences Private Limited (India) - Stratec Biomedical AG (Germany) - Straumann Holding AG (Switzerland) - Sunshine Holdings PLC (Sri Lanka) - Sysmex Corporation (Japan) - Thermo Fisher Scientific Inc (United States) - Tornier NV (Netherlands) - Toumaz Limited (United Kingdom) - TSO3 Inc (Canada) - Varian Medical Systems, Inc. (United States) - Vivoline Medical AB (Sweden) - Voxel SA (Poland) - William Demant Holding (Denmark) - Wound Management Technologies, Inc. (United States) - Yamato Scientific Co, Ltd (Japan) - Zecotek Photonics Inc (Canada) - Zhejiang DA Diagnostics Co Ltd (China) For more information visit http://www.researchandmarkets.com/research/mq...al_medical
VAR: 95.25 (+0.43), TRNX: 20.67 (+0.28)
200 Most Diversified Medical Devices/Technology/Supplies Companies Globally
M2 - Tue Oct 20, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lx7zxr/global_most) has announced the addition of the "Global Most Diversified Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Most Diversified medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information, and stock market analysis. The global medical device sector is a highly diversified and export-oriented industry that manufactures medical equipments as well as supplies. The purchasers for the same include hospitals, physician's offices, laboratories, clinics as well as patients (through direct purchases). The sector is populated with companies driven by product innovation. The industry is able to draw on world-class innovative research being conducted in global universities, research institutes, and hospitals, some of which has been spun-off into global medical device companies. Big, highly diversified medical technology companies are tapping into health-care spending spikes in emerging countries. That's in contrast to a U.S. market for medical devices that is mature and slow growing. Emerging market countries have large, aging populations and rising incomes, which equates to 15 percent revenue growth for medical technology companies from those countries. The medical devices/technology sector has become increasingly dominated by larger, diversified companies such as Medtronic, Johnson & Johnson, Boston Scientific Corporation, St. Jude Medical, Guidant Corporation, Stryker Corporation, Zimmer Medical Holdings, Vasomedical, Inc., Integra LifeSciences Holdings Corporation, and many more. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Most Diversified companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Highlights - Leading 200 Global Most Diversified medical devices/technology/supplies companies covered - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Most Diversified medical devices/technology/supplies companies - International presence of Global Most Diversified medical devices/technology/supplies companies - Key R&D activities by Global Most Diversified medical devices/technology/supplies companies Sample list of company names included in this industry report: - 3D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/lx...lobal_most
ATEC: 0.41 (unch), GBSNU: 16.22 (-0.28), MZOR: 23.20 (-0.33), FEIC: 106.68 (+0.12), BSX: 24.14 (unch), JNJ: 124.24 (+0.38), ZLTQ: 35.09 (+0.59), IARTV: 65.00 (-37.45), STJ: 83.90 (+0.45), BVX: 2.86 (+0.26), SYK: 114.90 (+0.05)
Cyberonics Set to Join the S&P MidCap 400; Ruckus Wireless to Join S&P SmallCap 600
PR Newswire - Mon Oct 05, 6:25PM CDT
S&P SmallCap 600 constituent Cyberonics Inc. (NASD:CYBX) will replace Home Properties Inc. (NYSE:HME) in the S&P MidCap 400, and Ruckus Wireless Inc. (NYSE:RKUS) will replace Cyberonics in the S&P SmallCap 600 after the close of trading on Wednesday, October 7. Lone Star Funds is acquiring Home Properties in a deal expected to be completed on or about that date, pending final approvals. Cyberonics is merging with Sorin SpA in a deal expected to be completed soon. Post merger, Cyberonics will change its name to LivaNova plc, and its combined market capitalization is anticipated to be more representative of the mid-cap market space.
HME: 75.24 (+0.01), MHFI: 107.92 (+1.16), RKUS: 12.87 (+0.15), CYBX: 69.95 (+0.86)
Cyberonics' stockholders approve business merger with Sorin to form LivaNova
M2 - Wed Sep 23, 5:05AM CDT
Medical device company Cyberonics (NASDAQ:CYBX) said on Tuesday that its stockholders have voted in favour with a merger and business combination with Sorin SpA (MTA; Reuters Code:SORN.MI)
CYBX: 69.95 (+0.86)
Analyzing the Market for Prosthetic Heart Valves in Russia 2015
M2 - Fri Aug 28, 9:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dpm69l/analyzing_the) has announced the addition of the "Analyzing the Market for Prosthetic Heart Valves in Russia 2015" report to their offering. This research analyzes the market for prosthetic heart valves in Russia in its research report Analyzing the Market for Prosthetic Heart Valves in Russia. The report begins with an overview of prosthetic heart valves. We look at both the mechanical heart valves and the biological heart valves along with the various issues that come up with prosthetic heart valves. The market for prosthetic heart valves is divided into two key types of valve: tissue or biological valves and mechanical heart valves. The tissue valve segment is the largest, with rapid growth expected in between 2014-2019. Mechanical valves remain popular with younger patients. A synthetic or mechanical or natural/biological valve that is surgically placed in place of the existing heart in order to replace the defective or malfunctioning valve is known as a prosthetic heart valve. The mitral and aortic valves are the most commonly replaced with prosthetic heart valves. The market for prosthetic heart valves is growing significantly in Russia especially the market for tissue heart valves. The reason behind this incredible growth is the technological advancements, combined with the launch of transcatheter valves, which is also driving procedure volumes in patients where surgery was not possible earlier due to its challenging nature. Major players in the Russian market for prosthetic heart valves are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic, Inc., amongst others. Key Topics Covered: A. Executive Summary B. Introduction to Prosthetic Heart Valves C. Market for Prosthetic Heart Valves in Russia D. Major Industry Players - Edwards Lifesciences Corporation - Medtronic, Inc - Sorin SpA - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/dp...lyzing_the
MDT: 87.09 (+0.33), STJ: 83.90 (+0.45), EW: 113.23 (+0.25)
Analyzing the Market for Prosthetic Heart Valves in China 2015
M2 - Fri Aug 28, 9:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8b3dbx/analyzing_the) has announced the addition of the "Analyzing the Market for Prosthetic Heart Valves in China 2015" report to their offering. This research analyzes the market for prosthetic heart valves in China in its research report Analyzing the Market for Prosthetic Heart Valves in China. The report begins with an overview of prosthetic heart valves. We look at both the mechanical heart valves and the biological heart valves along with the various issues that come up with prosthetic heart valves. A prosthetic heart valve is a synthetic or mechanical or natural/biological valve surgically placed into the heart to replace a defective or malfunctioning valve. The aortic and mitral valves are the most frequently replaced with prosthetic heart valves. The market for prosthetic heart valves is growing significantly in China, with technological advancements driving the growth, combined with the launch of transcatheter valves, which is also driving procedure volumes in patients where surgery was not possible earlier due to its risky nature. The market for prosthetic heart valves is divided into two key types of valve: tissue and mechanical heart valves. The tissue valve segment is the largest, with rapid growth expected over the reporting period. Mechanical valves remain popular with younger patients. Major players in the Chinese market for prosthetic heart valves are Edwards Lifesciences Corporation, Medtronic, Inc., St. Jude Medical, Inc., amongst others. Key Topics Covered: A. Executive Summary B. Introduction to Prosthetic Heart Valves C. Market for Prosthetic Heart Valves in China D. Major Industry Players - Edwards Lifesciences Corporation - Medtronic, Inc - Sorin SpA - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/8b...lyzing_the
MDT: 87.09 (+0.33), STJ: 83.90 (+0.45), EW: 113.23 (+0.25)
100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gjbtw4/randd_intensive) has announced the addition of the "R&D Intensive Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 R&D Intensive medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Over the past few years the way the medical devices industry assesses innovation and new technology has changed. The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. Recently, global market has been taking the lead in developing lean, frugal, and reverse innovation. This type of innovation simplifies devices and processes, retaining essential functions, while applying new technologies that are more versatile, mobile, and adaptable to consumer's needs and are less expensive. The global companies in medical devices/technology industry are highly R&D intensive and technology based. Such companies, on an average, spend 12% of their revenues on R&D each year in order to develop, design, and commercialize innovative medical devices. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the R&D Intensive companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - R&D Intensive 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of R&D Intensive medical devices/technology/supplies companies with foreign companies - International presence of R&D Intensive medical devices/technology/supplies companies - Key R&D activities by R&D Intensive medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of R&D Intensive Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 R&D Intensive Medical Devices/Technology/Supplies Companies 3: Key News of R&D Intensive Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of R&D Intensive Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by R&D Intensive Medical Devices/Technology/Supplies Companies 6: International Presence of R&D Intensive Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of R&D Intensive Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - 3 D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/gj..._intensive
ATEC: 0.41 (unch), GBSNU: 16.22 (-0.28), MZOR: 23.20 (-0.33), FEIC: 106.68 (+0.12), ZLTQ: 35.09 (+0.59), IART: 84.95 (+0.35), BVX: 2.86 (+0.26)
Leading 100 Medical Devices/Technology/Supplies Companies of Europe 2015
M2 - Mon Mar 23, 10:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wfwcrh/europe_medical) has announced the addition of the "Europe Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical technology is a key driver for Europe's economic well-being, providing quality employment, and a substantial contribution to Europe's balance of trade. The European medical technology market is estimated at roughly 100 billion and is the second largest medical technology market after US. It has been growing on average by 4% per annum over the past 6 years. Through its healthcare innovations, the European medical device industry contributes to ensuring sustainable and accessible healthcare systems throughout Europe. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the European companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Europe - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among European medical devices/technology/supplies companies - International presence of European medical devices/technology/supplies companies - R&D activities by European medical devices/technology/supplies companies Report Includes Companies Engaged in: - Manufacturing medical equipments providing any medical activity and/or treatment - Manufacturing diagnostic equipments - Manufacturing high-tech medical instruments - Manufacturing life-support medical equipments - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products - Manufacturing and/or selling basic medical and surgical materials (consumables), low-tech items and items used in medical equipment processor or for treating patients - Diagnostic equipment supplies - Medical supplies invasive and medical supplies non invasive - Manufacturing/supplying replaceable lenses for equipments - Manufacturing/supplying any item which needs to be replaced as a function of repeated medical activity or where need for treatments is constant - Manufacturing/supplying surgical and dental instruments, elective laser surgery equipments, orthopedic products, and other such products Companies Mentioned - Ion Beam Applications SA (Belgium) - Kitron ASA (Norway) - LiDCO Group PLC (United Kingdom) - MagForce AG (Germany) - Mauna Kea Technologies SAS (France) - Medica AD Sofia (Bulgaria) - Medicrea International (France) - Medisana AG (Germany) - Mercator Medical SA (Poland) - Nobel Biocare Holding AG (Switzerland) - Omega Diagnostics Group Plc (United Kingdom) - Orthofix International N.V. (Netherlands Antilles) - PuriCore PLC (United Kingdom) - PZ Cormay SA (Poland) - Sorin SpA (Italy) - Stentys (France) - Surgical Innovations Group PLC (United Kingdom) - Technoflex SA (France) - Voxel S.A. (Poland) For more information visit http://www.researchandmarkets.com/research/wf...pe_medical
OFIX: 42.42 (+0.13)
